Published in Elife on February 21, 2017
Mutations of Bacteria from Virus Sensitivity to Virus Resistance. Genetics (1943) 165.64
Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics (2010) 52.01
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol (2014) 27.48
Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol (1991) 19.65
Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics (2004) 19.05
Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol (2003) 16.82
A common mechanism of cellular death induced by bactericidal antibiotics. Cell (2007) 12.92
The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature (1992) 11.99
inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science (1994) 11.22
Estimation of bacterial densities by means of the "most probable number". Biometrics (1950) 10.81
Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med (1996) 8.94
Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev (1995) 7.55
Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell (2010) 5.33
Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'. Nat Rev Microbiol (2004) 5.19
Vancomycin resistance in gram-positive cocci. Clin Infect Dis (2006) 4.95
The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell (2000) 4.82
A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS One (2011) 4.59
The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. J Gen Microbiol (1986) 4.09
Mechanisms of resistance to quinolones. Clin Infect Dis (2005) 4.02
Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor. Nucleic Acids Res (2005) 4.00
Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog (2011) 3.89
Efflux-mediated antimicrobial resistance. J Antimicrob Chemother (2005) 3.69
Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biol (2005) 3.47
How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis (1998) 3.43
Aminoglycoside modifying enzymes. Drug Resist Updat (2010) 3.19
Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol (2012) 2.98
The population dynamics of antimicrobial chemotherapy. Antimicrob Agents Chemother (1997) 2.84
Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. Clin Infect Dis (2001) 2.81
The mutant selection window and antimicrobial resistance. J Antimicrob Chemother (2003) 2.77
Oxidation of the guanine nucleotide pool underlies cell death by bactericidal antibiotics. Science (2012) 2.72
The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria. Lancet Infect Dis (2013) 2.43
Drug interactions and the evolution of antibiotic resistance. Nat Rev Microbiol (2009) 2.40
Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother (1995) 2.36
Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis from multiple laboratories. J Bacteriol (2010) 2.36
Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations. J Infect Dis (2000) 2.35
Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proc Natl Acad Sci U S A (1996) 2.27
Antibiotics induce redox-related physiological alterations as part of their lethality. Proc Natl Acad Sci U S A (2014) 2.25
Proliferation and significance of clinically relevant β-lactamases. Ann N Y Acad Sci (2013) 2.05
Antibiotics targeting ribosomes: resistance, selectivity, synergism and cellular regulation. Annu Rev Biochem (2005) 1.99
Molecular aspects of methicillin resistance in Staphylococcus aureus. J Antimicrob Chemother (1994) 1.92
Global assessment of genomic regions required for growth in Mycobacterium tuberculosis. PLoS Pathog (2012) 1.85
Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin Microbiol Rev (2012) 1.74
Ribosomal protection proteins and their mechanism of tetracycline resistance. Antimicrob Agents Chemother (2003) 1.70
Antibiotic-selective environments. Clin Infect Dis (1998) 1.65
Introducing mutations into a chromosomal rRNA gene using a genetically modified eubacterial host with a single rRNA operon. Mol Microbiol (1996) 1.65
Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. Br Med Bull (2005) 1.56
RecA-Mediated gene conversion and aminoglycoside resistance in strains heterozygous for rRNA. Antimicrob Agents Chemother (1999) 1.51
Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target. Antimicrob Agents Chemother (2012) 1.43
Combination therapies for combating antimicrobial resistance. Curr Opin Microbiol (2011) 1.37
Tetracycline inhibition of cell-free protein synthesis. I. Binding of tetracycline to components of the system. J Bacteriol (1966) 1.25
Mutational reversions during adaptive protein evolution. Mol Biol Evol (2007) 1.24
Molecular cloning and functional analysis of a novel tetracycline resistance determinant, tet(V), from Mycobacterium smegmatis. Antimicrob Agents Chemother (1998) 1.24
Induction and inhibition of ciprofloxacin resistance-conferring mutations in hypermutator bacteria. Antimicrob Agents Chemother (2006) 1.24
Is there a unique ribosome phenotype for naturally occurring Escherichia coli? Biochimie (1992) 1.22
Selective advantage of resistant strains at trace levels of antibiotics: a simple and ultrasensitive color test for detection of antibiotics and genotoxic agents. Antimicrob Agents Chemother (2011) 1.19
Application of RNA-seq to reveal the transcript profile in bacteria. Genet Mol Res (2011) 1.17
Evolution of antibiotic resistance at non-lethal drug concentrations. Drug Resist Updat (2012) 1.17
Combination therapy as a tool to prevent emergence of bacterial resistance. Infection (1999) 1.17
Strategies to minimize the development of antibiotic resistance. J Chemother (1997) 1.16
Antimicrobials as promoters of genetic variation. Curr Opin Microbiol (2012) 1.15
A new evolutionary and pharmacokinetic-pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs. Curr Opin Pharmacol (2011) 1.15
Inactivation of ribosomal protein genes in Bacillus subtilis reveals importance of each ribosomal protein for cell proliferation and cell differentiation. J Bacteriol (2012) 1.12
Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa. Trop Med Int Health (2010) 1.10
Systematic chromosomal deletion of bacterial ribosomal protein genes. J Mol Biol (2011) 1.10
Spontaneous emergence of multiple drug resistance in tuberculosis before and during therapy. PLoS One (2011) 1.09
The mycobacterial transcriptional regulator whiB7 gene links redox homeostasis and intrinsic antibiotic resistance. J Biol Chem (2011) 1.06
Simultaneous generation of many RNA-seq libraries in a single reaction. Nat Methods (2015) 1.00
Preparation of Single-Cell RNA-Seq Libraries for Next Generation Sequencing. Curr Protoc Mol Biol (2014) 0.99
Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance. FEMS Microbiol Lett (2000) 0.94
Noncanonical SMC protein in Mycobacterium smegmatis restricts maintenance of Mycobacterium fortuitum plasmids. Proc Natl Acad Sci U S A (2014) 0.90
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis. Antimicrob Agents Chemother (2006) 0.88
The inhibition pattern of antibiotics on the extent and accuracy of tRNA binding to the ribosome, and their effect on the subsequent steps in chain elongation. Eur J Biochem (1983) 0.85
Partial removal of bound transfer RNA from polysomes engaged in protein synthesis in vitro after addition of tetracycline. Biochim Biophys Acta (1967) 0.84
A complex regulatory network controlling intrinsic multidrug resistance in Mycobacterium smegmatis. Mol Microbiol (2013) 0.82
Role of pharmacogenomics in the treatment of tuberculosis: a review. Pharmgenomics Pers Med (2012) 0.82
Nucleic acid detection with CRISPR-Cas13a/C2c2. Science (2017) 0.85
Systematic, multiparametric analysis of Mycobacterium tuberculosis intracellular infection offers insight into coordinated virulence. PLoS Pathog (2017) 0.75